[1] |
Cai K, Ma Y, Cai F, et al. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury[J]. Endocrine, 2022, 76(2): 294-303.
|
[2] |
Bao N, Ding T, Gao Y, et al. Diversity of Intestinal Flora in Elderly Patients with Type 2 Diabetes Mellitus with Early Nephropathy[J]. J Clin Nurs Res, 2023, 7(6): 167-171.
|
[3] |
李雷, 张帆, 方飞, 等. 糖尿病肾病患者肠道菌群分布变化与炎症指标相关性分析[J]. 中华内分泌外科杂志, 2020, 14(6): 507-510.
|
[4] |
Du X, Liu J, Xue Y, et al. Alteration of gut microbial profile in patients with diabetic nephropathy[J]. Endocrine, 2021, 73(1): 71-84.
|
[5] |
Lang R, Wang XH, Li AF, et al. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: A prospective randomized controlled trial[J]. Chron Dis Transl Med, 2020, 6(2): 124-133.
|
[6] |
郭世强, 刘春林, 吴清念. 糖尿病肾病患者肠道菌群及炎症因子变化的临床意义[J]. 中国当代医药, 2022, 29(21): 23-26.
|
[7] |
Wang F, Liu C, Ren LZ, et al. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway[J]. Pharm Biol, 2023, 61(1): 427-436.
|
[8] |
Shi R, Tao Y, Tang H, et al. Abelmoschus Manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non‐obese diabetes mice[J]. Microb Biotechnol, 2023, 16(4): 813-826.
|
[9] |
Shi X, Li Z, Lin W, et al. Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy[J]. Am J Nephrol, 2023, 54(11-12): 451-470.
|
[10] |
姚碧晴, 陈铖. 肠道菌群失调与糖尿病肾病的关系[J]. 中华实用诊断与治疗杂志, 2020, 34(1): 102-105.
|
[11] |
冯春念, 曾琳智, 王仕均, 等. 2型糖尿病与糖尿病肾病患者微炎症及肠道微生物多样性分析[J]. 中国微生态学杂志, 2020, 32(11): 1273-1278.
|
[12] |
Meng X, Ma J, Kang SY, et al. Jowiseungki decoction affects diabetic nephropathy in mice through renal injury inhibition as evidenced by network pharmacology and gut microbiota analyses[J]. Chin Med, 2020, 15(1): 1-19.
|
[13] |
Xu X, Wang H, Guo D, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy[J]. Ren Fail, 2021, 43(1): 1063-1075.
|
[14] |
褚欢, 李雷. 老年2型糖尿病早期肾病患者肠道菌群多样性[J]. 中国微生态学杂志, 2021, 33(8): 916-919.
|
[15] |
Pan L, Han P, Ma S, et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia[J]. Acta Pharm Sin B, 2020, 10(2): 249-261.
|
[16] |
冯真真, 钱磊, 赵琳, 等. 2型糖尿病和糖尿病肾病患者肠道菌群失衡模式及功能变化的研究[J]. 胃肠病学和肝病学杂志, 2022, 31(2): 203-207.
|
[17] |
Rizk FH, El Saadany AA, Atef MM, et al. Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy: Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis[J]. Pflugers Arch, 2023, 475(10): 1161-1176.
|
[18] |
Yu W, Shang J, Guo R, et al. The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy [J]. Ren Fail, 2020, 42(1): 1100-1110.
|